Harbin Gloria Partners with Genolmmune on PD-1 and Neoantigen Therapy for NSCLC
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has partnered with Genolmmune Therapeutics Biotechnology Co.,...
Genomics / NGS
Mega Genomics Limited Makes Hong Kong IPO Debut at HKD 18 Per Share
China-based gene testing platform company Mega Genomics Limited has successfully completed an initial public offering...